Erlotinib Hydrochloride | API DMFs | US Drug Master File (DMF) Details | Pharmacompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Erlotinib Hydrochloride
USDMF

Evonik

Contact Supplier

Fishfa Biogenics: Renowned Manufacturer, & Exporter of Tacrolimus & Mupirocin API.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Erlotinib Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

53 API Suppliers, 28 USDMF, 1 JDMF, 16 EU WC, 14 KDMF, 15 NDC API, 28 Listed Suppliers, $ API Reference Price

53 API Suppliers
28 USDMF
1 JDMF
16 EU WC
14 KDMF
15 NDC API
28 Listed Suppliers
$ API Reference Price

INTERMEDIATES

3 API Suppliers

3 API Suppliers

FINISHED DOSAGE FORMULATIONS

73 FDF Dossiers, 41 FDA Orange Book, 3 Europe, 14 Canada, 11 South Africa, 4 Listed Dossiers

73 FDF Dossiers
41 FDA Orange Book
3 Europe
14 Canada
11 South Africa
4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 2 DKSH, 9 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 5 BASF, 10 Corel Pharma Chem, 5 DFE Pharma, 5 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 29 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 10 Microlex e.U, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 11 Roquette, 6 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 2 The Dow Chemical Company, 3 Vasa Pharmachem

1 SPI Pharma
2 DKSH
9 Gangwal Healthcare
1 Nanjing Well Pharmaceutical
1 ACG Worldwide
4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
5 BASF
10 Corel Pharma Chem
5 DFE Pharma
5 Gangwal Chemicals
5 Ideal Cures Pvt Ltd
1 Ingredion Pharma Solutions
29 Kerry
3 Kima Chemical
6 Lonza Capsugel
10 Microlex e.U
1 Novo Excipients
2 Pharmatrans-Sanaq
3 Pluviaendo
3 Prachin Chemical
1 Qianhao Chemical (Hebei) Co., Ltd
1 Qualicaps
11 Roquette
6 Seppic
3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
10 Sigachi Industries
2 The Dow Chemical Company
3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

45 Coating Systems & Additives, 42 Fillers, Diluents & Binders, 21 Direct Compression, 21 Controlled & Modified Release, 15 Disintegrants & Superdisintegrants, 14 Granulation, 13 Lubricants & Glidants, 12 Thickeners and Stabilizers, 11 Co-Processed Excipients, 7 Film Formers & Plasticizers, 6 Taste Masking, 5 Empty Capsules, 4 Coloring Agents, 4 Vegetarian Capsules, 3 Chewable & Orodispersible Aids, 3 API Stability Enhancers, 2 Emulsifying Agents, 2 Rheology Modifiers, 1 Solubilizers, 1 Topical, 1 Parenteral, 1 Surfactant & Foaming Agents

45 Coating Systems & Additives
42 Fillers, Diluents & Binders
21 Direct Compression
21 Controlled & Modified Release
15 Disintegrants & Superdisintegrants
14 Granulation
13 Lubricants & Glidants
12 Thickeners and Stabilizers
11 Co-Processed Excipients
7 Film Formers & Plasticizers
6 Taste Masking
5 Empty Capsules
4 Coloring Agents
4 Vegetarian Capsules
3 Chewable & Orodispersible Aids
3 API Stability Enhancers
2 Emulsifying Agents
2 Rheology Modifiers
1 Solubilizers
1 Topical
1 Parenteral
1 Surfactant & Foaming Agents

DIGITAL CONTENT

12 NEWS #PharmaBuzz

12 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 3 Finished Drug Prices

1 US Medicaid Prescriptions
3 Finished Drug Prices

MARKET PLACE

3 APIs, 1 FDF Dossiers

3 APIs
1 FDF Dossiers

REF. STANDARDS & IMPURITIES

1 Others

1 Others

$ API Ref.Price (USD/KG) : 3,690 Xls

Filters

Reset all filters

Filters

FILTER :

filter Holder Reset all filters

28 All

01 1Acebright India Pharma Private Limited

02 1Alembic Pharmaceuticals Limited

03 1Apotex Pharmachem

04 1Asymchem Laboratories

05 1Cambrex Corporation

06 1Cdymax

07 1Cipla

08 1Esteve Huayi Pharmaceutical

09 1F.I.S. Fabbrica Italiana Sintetici

10 1Hetero Drugs

11 1Hikma Pharmaceuticals

12 1Intas Pharmaceuticals

13 1Laurus Labs

14 2MSN Laboratories

15 1Natco Pharma

16 1Qilu Antibiotics Pharmaceutical Co., Ltd.

17 1Reliance Life Sciences Private Limited

18 1Shilpa Medicare

19 1Sichuan Xieli Pharmaceutical

20 1Sun Pharmaceutical Industries Limited

21 1Tai Heng Industry Co., Ltd

22 1Teva API

23 2Viatris

24 1Zhejiang Jiuzhou Pharmaceutical

25 2Zydus Lifesciences

filter Subject Reset all filters

28 All

01 1ERLOTINIB HYDROCHLORIDE

02 1ERLOTINIB HCL

03 19ERLOTINIB HYDROCHLORIDE

04 1ERLOTINIB HYDROCHLORIDE (ET)

05 1ERLOTINIB HYDROCHLORIDE (FORM-A)

06 2ERLOTINIB HYDROCHLORIDE (FORM-B)

07 1ERLOTINIB HYDROCHLORIDE (NON-STERILE DRUG SUBSTANCE)

08 1ERLOTINIB HYDROCHLORIDE [DRUG SUBSTANCE (NON-STERILE)]

09 1ERLOTINIB HYDROCHLORIDE [ROUTE CODE - "ER"]

filter Country Reset all filters

28 All

01 1Canada

02 5China

03 15India

04 1Israel

05 1Italy

06 4U.S.A

07 1United Kingdom

filter Status Reset all filters

28 All

01 19Active

02 9Inactive

filter GDUFA DMF Review Reset all filters

28 All

01 17Complete

02 11Blank

List of Suppliers

Product Main Page

01

Apotex Pharmachem Inc

USDMF

2024 ACI Convention

Not Confirmed

01

Apotex Pharmachem Inc

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Erlotinib Hydrochloride

GDUFA

DMF Review : Complete

Rev. Date : 2014-10-28

Pay. Date : 2012-12-12

DMF Number : 26631

Submission : 2013-01-22

Status : Active

Type : II

Product Web Link

Digital Content

Corporate PDF

02

Cipla Ltd

USDMF

2024 ACI Convention

Not Confirmed

02

Cipla Ltd

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Erlotinib Hydrochloride

GDUFA

DMF Review : Complete

Rev. Date : 2018-10-16

Pay. Date : 2018-09-24

DMF Number : 29638

Submission : 2015-09-01

Status : Active

Type : II

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Hetero Labs Ltd

USDMF

2024 ACI Convention

Not Confirmed

03

Hetero Labs Ltd

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Erlotinib Hydrochloride

GDUFA

DMF Review : Complete

Rev. Date : 2016-06-08

Pay. Date : 2016-04-22

DMF Number : 26116

Submission : 2012-06-04

Status : Active

Type : II

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Hikma Pharmaceuticals Plc

USDMF

2024 ACI Convention

Not Confirmed

04

Hikma Pharmaceuticals Plc

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Erlotinib Hydrochloride

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 29437

Submission : 2015-05-28

Status : Active

Type : II

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Msn Laboratories Private Ltd

USDMF

2024 ACI Convention

Not Confirmed

05

Msn Laboratories Private Ltd

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Erlotinib Hydrochloride [route Code - "er"]

GDUFA

DMF Review : Complete

Rev. Date : 2015-12-08

Pay. Date : 2015-09-23

DMF Number : 27042

Submission : 2013-05-31

Status : Active

Type : II

Product Web Link

Digital Content

Corporate PDF

06

Natco Pharma Ltd

USDMF

2024 ACI Convention

Not Confirmed

06

Natco Pharma Ltd

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Erlotinib Hydrochloride

GDUFA

DMF Review : Complete

Rev. Date : 2015-06-09

Pay. Date : 2015-05-27

DMF Number : 21786

Submission : 2008-07-11

Status : Active

Type : II

Product Web Link

Digital Content

Corporate PDF

07

Reliance Life Sciences Pvt Ltd

USDMF

2024 ACI Convention

Not Confirmed

07

Reliance Life Sciences Pvt Ltd

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Erlotinib Hydrochloride

GDUFA

DMF Review : Complete

Rev. Date : 2021-03-05

Pay. Date : 2021-01-20

DMF Number : 25978

Submission : 2012-05-16

Status : Active

Type : II

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

Shilpa Pharma Lifesciences Ltd

USDMF

2024 ACI Convention

Not Confirmed

08

Shilpa Pharma Lifesciences Ltd

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Erlotinib Hydrochloride (et)

GDUFA

DMF Review : Complete

Rev. Date : 2015-12-04

Pay. Date : 2015-04-10

DMF Number : 29124

Submission : 2015-04-13

Status : Active

Type : II

Product Web Link

Digital Content

09

Sichuan Xieli Pharmaceutical Co Ltd

USDMF

2024 ACI Convention

Not Confirmed

09

Sichuan Xieli Pharmaceutical Co Ltd

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Erlotinib Hydrochloride

GDUFA

DMF Review : Complete

Rev. Date : 2016-04-01

Pay. Date : 2015-06-09

DMF Number : 26388

Submission : 2012-09-12

Status : Active

Type : II

Product Web Link

Digital Content

Corporate PDF

10

Teva Pharmaceutical Industries Ltd

USDMF

2024 ACI Convention

Not Confirmed

10

Teva Pharmaceutical Industries Ltd

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Erlotinib Hcl

GDUFA

DMF Review : Complete

Rev. Date : 2012-11-23

Pay. Date : 2012-11-08

DMF Number : 23183

Submission : 2009-10-16

Status : Active

Type : II

Product Web Link

Digital Content

Corporate PDF

1
2
3

Erlotinib Hydrochloride Manufacturers | Traders | Suppliers

Erlotinib Hydrochloride Manufacturers, Traders, Suppliers 1

15

We have 25 companies offering Erlotinib Hydrochloride

Get in contact with the supplier of your choice:

Acebright India Pharma Private Limited
Alembic Pharmaceuticals Limited
Apotex Pharmachem
Asymchem Laboratories
Cambrex Corporation
Cdymax
Cipla
Esteve Huayi Pharmaceutical
F.I.S. Fabbrica Italiana Sintetici
Hetero Drugs
Hikma Pharmaceuticals
Intas Pharmaceuticals
Laurus Labs
MSN Laboratories
Natco Pharma
Qilu Antibiotics Pharmaceutical Co., Ltd.
Reliance Life Sciences Private Limited
Shilpa Medicare
Sichuan Xieli Pharmaceutical
Sun Pharmaceutical Industries Limited
Tai Heng Industry Co., Ltd
Teva API
Viatris
Zhejiang Jiuzhou Pharmaceutical
Zydus Lifesciences

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?